CDCP1 is a transmembrane glycosylated receptor protein known to be overexpressed in pancreatic cancers, including PDAC, and co-expression of CDCP1 and uPA has been found to be strongly predictive of poor clinical outcome in various cancer types [245,246]. Here, PLAU is linked to cancer.